30 Maggio 2025 · Dott. Gianfrancesco Cormaci
Type 2 diabetes (T2D) is a rapidly growing metabolic condition worldwide characterized by increased blood glucose levels during fasting or after food consumption. T2D…
Leggi →
23 Ottobre 2023 · Dott. Gianfrancesco Cormaci
More than 12,000 people in the United States are diagnosed with a neuroendocrine tumor each year. The tumors begin in neuroendocrine cells – which…
Leggi →
16 Marzo 2019 · Dott. Gianfrancesco Cormaci
Scientists have long known that excess body weight increases women’s risks of ER-positive breast cancer after menopause, but the specific metabolic pathways and genetic…
Leggi →
10 Marzo 2019 · Dott. Gianfrancesco Cormaci
A protein known to play a role in cancer may also be increasing fibrosis in scleroderma patients. Systemic sclerosis (Scleroderma, SSc) is a systemic…
Leggi →
2 Marzo 2019 · Dott. Gianfrancesco Cormaci
An estimated 1 in 5 women with breast cancer have a mutation in their tumor cells that produces excess amounts of human epidermal growth factor receptor…
Leggi →
6 Febbraio 2019 · Dott. Gianfrancesco Cormaci
Stem cells are vital for therapeutic treatments to repair and build human tissue like bone marrow, skin and muscles. Stem cells are increasingly being…
Leggi →
23 Gennaio 2019 · Dott. Gianfrancesco Cormaci
Nicotinamide riboside (NR) is a cell-charging vitamin clinically proven to boost NAD, a critical coenzyme as essential to cells as food, water, and oxygen.…
Leggi →
29 Dicembre 2018 · Dott. Gianfrancesco Cormaci
Myelofibrosis is a severe and very rare hematological disease for which treatment has only been partially effective to date. It is a Philadelphia chromosome-negative…
Leggi →
29 Ottobre 2018 · Dott. Gianfrancesco Cormaci
Belgian research groups from the UCLouvain and WELBIO, VIB and Ghent University, and the biotechnology company Argenx elucidated the three-dimensional structure of an assembly…
Leggi →